DNGH Financials 07/15/2014 22:12:51 Dongsheng Pha
Post# of 3
Posted On: 07/15/2014 11:12:48 PM
DNGH Financials 07/15/2014 22:12:51
Dongsheng Pharmaceutical International Co. Ltd.
Period Ending Jun 30, 2010
Total Revenue 20,479
Cost of Revenue 15,169
Gross Profit 5,311
Operating Expenses
Research and Development -
Sales, General and Admin. 1,241
Non-Recurring Items (1,442)
Other -
Operating Income 5,511
Income From Continuing Operations
Add'l Income/Expense Items (94)
Earnings Before Interest and Tax 5,417
Interest Expense 5
Earnings Before Tax 5,412
Income Tax 1,355
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 4,057
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 4,057
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 4,057
Dongsheng Pharmaceutical International Co. Ltd.
Period Ending Jun 30, 2010
Total Revenue 20,479
Cost of Revenue 15,169
Gross Profit 5,311
Operating Expenses
Research and Development -
Sales, General and Admin. 1,241
Non-Recurring Items (1,442)
Other -
Operating Income 5,511
Income From Continuing Operations
Add'l Income/Expense Items (94)
Earnings Before Interest and Tax 5,417
Interest Expense 5
Earnings Before Tax 5,412
Income Tax 1,355
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 4,057
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 4,057
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 4,057
(0)
(0)Dongsheng Pharma (DNGH) Stock Research Links
Scroll down for more posts ▼